Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356546 · ClinicalTrials.gov registry record
TYRX™ Pocket Health Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 36
- Enrollment target
NCT05356546: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT05356546 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356546 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Medtronic, Inc. is sponsoring the TYRX™ Pocket Health Study to evaluate the histological and morphometric parameters of the device capsule in participants who underwent a cardiovascular implantable electronic device (CIED) procedure with a TYRX™ Absorbable Antibacterial Envelope and are returning for a CIED replacement procedure.
Primary Outcome
Measurement of capsule wall thickness (measured in millimeters, mm) in tissue sample
Interventions
- OTHER Study-required procedures include: tissue collection from device capsule, questionnaire collection, and photo collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2023-07-06 |
What the finished NCT05356546 record still lists
NCT05356546 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Study-required procedures include: tissue collection from device capsule, questionnaire collection, and photo collection is the first listed.
NCT05356546 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05356546 about?
NCT05356546 is a clinical study titled "TYRX™ Pocket Health Study". Medtronic, Inc. is sponsoring the TYRX™ Pocket Health Study to evaluate the histological and morphometric parameters of the device capsule in participants who underwent a cardiovascular implantable electronic device (CIED) procedure with a TYRX™ Absorbable Antibacterial Envelope and are returning fo...
What is the current status of trial NCT05356546?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2022-05-31. Estimated completion is 2023-07-06.
What interventions are being tested in trial NCT05356546?
The interventions under investigation include: Study-required procedures include: tissue collection from device capsule, questionnaire collection, and photo collection (OTHER).
Who is sponsoring clinical trial NCT05356546?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI